Peptide Sample Traceability: UK Laboratory Guide

Laboratory Sample Traceability: Records, Labels and Audit Trails

Laboratory sample traceability is the ability to follow a research specimen from receipt through storage, preparation, analysis and final reporting. For peptide research, a reliable record connects a particular vial or aliquot to its source, identifier, handling history, analytical run and result. This is a documentation and measurement-quality discipline, not evidence that a material is suitable for human use.

A chromatogram or mass spectrum is more useful when the laboratory can demonstrate which sample was measured, what happened to it beforehand and which instrument and reference materials were used. This guide explains the distinctions between chain of custody, sample traceability and metrological traceability, and outlines a practical, risk-based approach for UK laboratories.

Three kinds of traceability that should not be confused

Sample identity and provenance

Sample identity answers “which physical material produced this result?” Provenance records where the sample came from and how it was received. Useful fields include a unique laboratory sample ID, supplier or project reference, lot or batch reference when provided, material description, receipt date, container condition and the person accepting it. A batch label alone is not enough if multiple aliquots or test preparations share that batch identifier.

Chain of custody

Chain of custody records possession and transfers of a specimen. It can identify the person, time, location and purpose of each handover. The level of formality depends on the study: a routine internal research experiment may need a simpler record than a forensic or regulated study. Chain of custody is primarily about who controlled the specimen, not whether an instrument was correctly calibrated.

Metrological traceability

Metrological traceability concerns a measurement result, which is related to a stated reference through a documented chain of calibrations and associated uncertainty. The US National Institute of Standards and Technology (NIST) explicitly cautions that using one calibrated instrument does not automatically make every resulting measurement traceable. See its metrological traceability guidance. In peptide analysis, sample history and measurement traceability complement one another but must be evidenced separately.

Build a sample record at receipt

The first record should be created before a sample moves into routine laboratory storage. Assign a unique identifier that cannot be mistaken for a supplier product name. Record the stated material identity without treating the label as independent proof of identity. Where applicable, capture supplier reference, purchase or project number, lot reference, quantity received, packaging description, receipt condition and any discrepancy. A receipt photo may be useful if permitted by the laboratory’s data-governance policy.

Keep the original supplier description and the laboratory’s verified analytical conclusion as separate fields. For example, “label states peptide X” is a provenance fact; “identity supported by mass spectrometry” is an analytical interpretation that requires its own data and acceptance criteria. For background on that distinction, see the site’s peptide mass spectrometry identity-testing guide.

Use a unique ID for every aliquot and preparation

When a parent sample is divided, each daughter aliquot needs an identifier linked back to the parent. A clear naming convention can use a project prefix, sequential sample number and aliquot suffix, but should not encode confidential information. A traceability table should identify parent-child relationships, the preparation date, responsible analyst, preparation record and disposition.

For any subsequent dilution or extraction, record what was done at the level needed to interpret the result. Include the applicable procedure revision, source aliquot, relevant reagent or solvent lot, equipment ID, calculation or preparation reference, and any deviation. An unexplained renaming step breaks the link between material and result even when the analytical instrument itself performs correctly.

Connect storage history to the analytical result

Sample condition can change with time and environment. Peptide stability depends on molecular sequence, formulation, matrix, moisture, light exposure and other study-specific factors; no universal shelf life can be inferred from the word “peptide”. Record storage location, any required monitored conditions, moves between locations, and significant excursions against the study’s predefined requirements. If temperature is measured, keep the monitoring-device identifier and relevant calibration or verification records.

Do not silently discard samples that experience an excursion. Document the event, assess whether the material remains fit for the intended analysis, and record the decision and its justification. A repeat analysis may help investigate an issue, but it does not retroactively erase a break in custody or missing environmental data. The site’s peptide storage overview provides related context; the applicable laboratory SOP remains authoritative.

Link analytical runs to source data

Every result should point to an analytical sequence or run identifier, instrument, method version, analyst, calibration and suitability checks, relevant reference materials, and original raw-data location. Preserve the distinction between raw data, processed data and the final report. Where software supports an audit trail, record material changes and reasons rather than overwriting earlier entries.

For chromatographic work, traceability should connect the injected preparation to the integration report and any reintegration decision. The HPLC peptide purity-testing guide explains what a chromatographic purity estimate can and cannot establish. A percentage of chromatographic peak area does not by itself prove molecular identity, total mass purity, absence of every impurity or biological suitability.

Design an audit trail that answers real questions

A useful audit trail is chronological, attributable and difficult to alter without detection. It should answer: Who received the sample? Which container was used? When was an aliquot prepared? Which method produced the result? Was an out-of-specification or unexpected observation investigated? Who reviewed the conclusion? If electronic systems are used, role-based access, time synchronisation, version history, backup and documented correction procedures help preserve the meaning of the record.

Not every laboratory needs a large laboratory information management system. A controlled register can work for a small research operation if identifiers are unique, access is managed, changes remain reviewable and records can be retrieved. Conversely, purchasing software alone does not create good traceability: the process must be followed consistently.

UK laboratory quality and regulatory context

UK Good Laboratory Practice (GLP) requirements apply to defined regulatory safety studies, not automatically to every exploratory peptide experiment. The Medicines and Healthcare products Regulatory Agency explains the scope and compliance monitoring programme in its official UK GLP guidance. Laboratories should determine whether a specific project is regulated and obtain qualified advice when needed rather than advertising general “GLP compliance” without evidence.

For analytical methods supporting pharmaceutical regulatory submissions, the ICH Q2(R2) validation guideline addresses performance characteristics such as specificity, accuracy, precision and range. Its applicability depends on the work being performed; it is not a blanket certification of a peptide supplier or research sample. Method validation, sample traceability and appropriate quality oversight address different questions.

What to include in a sample-traceability checklist

Receipt: unique ID, source, stated material, batch or lot reference, receipt condition, date and responsible person.
Aliquots: parent-child identifier, preparation record, procedure version, reagent references and analyst.
Storage: location, relevant environmental record, transfers, excursions and documented assessments.
Testing: instrument and method identifiers, sequence/run ID, suitability checks, reference materials and raw-data location.
Review: calculations, exceptions, corrective notes, reviewer and approved report version.
Retention: project-specific retention policy, access controls, backup and final disposition.

Apply the checklist proportionately. A meaningful record should make the experiment reproducible and the report interpretable without collecting unnecessary personal data or asserting a quality status that has not been demonstrated.

Frequently asked questions

Is a certificate of analysis the same as sample traceability?

No. A certificate may summarise tests on a stated batch, but it does not by itself document the custody, storage and preparation of a particular specimen in another laboratory. See how to read a peptide certificate of analysis for interpreting reported tests.

Does a batch number uniquely identify every aliquot?

Usually not. A batch can contain many containers and aliquots. Individual laboratory IDs and documented parent-child relationships prevent mix-ups.

Does traceability prove peptide purity?

No. Traceability documents the sample and measurement history. Purity is an analytical question requiring a suitable method, data and interpretation.

Must every UK peptide research laboratory join the GLP programme?

No. The UK GLP monitoring programme applies to defined regulatory safety-testing activities. The scope of each project should be assessed against the applicable requirements.

What is the simplest improvement a small laboratory can make?

Assign unique sample and aliquot IDs and require each result to reference the original specimen, preparation record and raw analytical data. Review the records periodically for missing links.

Laboratory Sample Traceability for Peptide Research: UK Guide